Paper33615840
CGRP monoclonal antibody prevents the loss of diffuse noxious inhibitory controls (DNIC) in a mouse model of post-traumatic headache.
Kopruszinski CM and 8 others. Cephalalgia, 2021. Cited by 32 papers, by iCite.
Cite this record
ConductScience Library. CGRP monoclonal antibody prevents the loss of diffuse noxious inhibitory controls (DNIC) in a mouse model of post-traumatic headache. Papers, record 33615840. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33615840
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- CGRP monoclonal antibody prevents the loss of diffuse noxious inhibitory controls (DNIC) in a mouse model of post-traumatic headache.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Brain Concussion | Major topic |
| Calcitonin Gene-Related Peptide | Major topic |
| Diffuse Noxious Inhibitory Control | Major topic |
| Neuralgia | Major topic |
| Post-Traumatic Headache | Major topic |
| Animals | |
| Antibodies, Monoclonal | |
| Calcitonin | |
| Capsaicin | |
| Chronic Pain | |
| Disease Models, Animal | |
| Hyperalgesia | |
| Male | |
| Mice | |
| Mice, Inbred C57BL |
Source PubMed
Cited by24
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41772436 | Hallmarks of headache disorders: part 5 - secondary headaches. | J Headache Pain | 2026 | https://conductscience.org/library/papers/41772436 | PubMed |
| 41102655 | OnabotulinumtoxinA inhibits dysregulation of descending pain modulation following mild traumatic brain injury in mice. | J Headache Pain | 2025 | https://conductscience.org/library/papers/41102655 | PubMed |
| 40760469 | Pretreatment with an anti-CGRP monoclonal antibody attenuates mild TBI-induced tactile hypersensitivity in mice. | J Headache Pain | 2025 | https://conductscience.org/library/papers/40760469 | PubMed |
| 40410204 | Exercise plasma improves traumatic brain injury outcomes in mice. | Sci Rep | 2025 | https://conductscience.org/library/papers/40410204 | PubMed |
| 40036725 | Efficacy of MEDI0618, a pH-dependent monoclonal antibody targeting PAR2, in preclinical models of migraine. | Brain | 2025 | https://conductscience.org/library/papers/40036725 | PubMed |
| 39810127 | Differentially localizing isoforms of the migraine component calcitonin gene-related peptide (CGRP), in the mouse trigeminal ganglion: βCGRP is translated but, unlike αCGRP, not sorted into axons. | J Headache Pain | 2025 | https://conductscience.org/library/papers/39810127 | PubMed |
| 39058958 | Descending facilitation from rostral ventromedial medulla mu opioid receptor-expressing neurons is necessary for maintenance of sensory and affective dimensions of chronic neuropathic pain. | Pain | 2025 | https://conductscience.org/library/papers/39058958 | PubMed |
| 39009744 | Posttraumatic headache: pain related evoked potentials (PREP) and conditioned pain modulation (CPM) to assess the pain modulatory function. | Sci Rep | 2024 | https://conductscience.org/library/papers/39009744 | PubMed |
| 38890563 | Hypersensitivity to BKCa channel opening in persistent post-traumatic headache. | J Headache Pain | 2024 | https://conductscience.org/library/papers/38890563 | PubMed |
| 38713368 | Can Long-Term Outcomes of Posttraumatic Headache be Predicted? | Curr Pain Headache Rep | 2024 | https://conductscience.org/library/papers/38713368 | PubMed |
| 38575868 | CGRP-targeted medication in chronic migraine - systematic review. | J Headache Pain | 2024 | https://conductscience.org/library/papers/38575868 | PubMed |
| 38016977 | Identification of brain areas in mice with peak neural activity across the acute and persistent phases of post-traumatic headache. | Cephalalgia | 2023 | https://conductscience.org/library/papers/38016977 | PubMed |
| 37957260 | Idiopathic intracranial hypertension: a step change in understanding the disease mechanisms. | Nat Rev Neurol | 2023 | https://conductscience.org/library/papers/37957260 | PubMed |
| 37865340 | Mechanisms and treatments of chronic pain after traumatic brain injury. | Neurochem Int | 2023 | https://conductscience.org/library/papers/37865340 | PubMed |
| 37691118 | Mode and site of action of therapies targeting CGRP signaling. | J Headache Pain | 2023 | https://conductscience.org/library/papers/37691118 | PubMed |
| 37569575 | Calcitonin Gene-Related Peptide-Mediated Trigeminal Ganglionitis: The Biomolecular Link between Temporomandibular Disorders and Chronic Headaches. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37569575 | PubMed |
| 37316796 | Repeat mild traumatic brain injuries (RmTBI) modify nociception and disrupt orexinergic connectivity within the descending pain pathway. | J Headache Pain | 2023 | https://conductscience.org/library/papers/37316796 | PubMed |
| 37271350 | Effect of Voluntary Exercise on Endogenous Pain Control Systems and Post-traumatic Headache in Mice. | J Pain | 2023 | https://conductscience.org/library/papers/37271350 | PubMed |
| 36611947 | Preclinical Studies of Posttraumatic Headache and the Potential Therapeutics. | Cells | 2022 | https://conductscience.org/library/papers/36611947 | PubMed |
| 36454715 | CGRP physiology, pharmacology, and therapeutic targets: migraine and beyond. | Physiol Rev | 2023 | https://conductscience.org/library/papers/36454715 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33615840
GET https://conductscience.org/api/papers/v1/33615840/cited_by?page=2